SGMO
Sangamo Therapeutics Inc
NASDAQ: SGMO · HEALTHCARE · BIOTECHNOLOGY
$0.12
-10.24% today
Updated 2026-04-30
Market cap
$78.75M
P/E ratio
—
P/S ratio
1.99x
EPS (TTM)
$-0.44
Dividend yield
—
52W range
$0 – $1
Volume
7.8M
Sangamo Therapeutics Inc (SGMO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-14.48M | $-16.07M | $-17.34M | $-6.14M | $-23.93M | $-25.89M | $-8.08M | $-19.48M | $-5.67M | $-33.72M | $-65.88M | $11.18M | $37.15M | $-144.40M | $169.88M | $-233.25M | $-223.63M | $-224.84M | $-67.14M | $-97.21M |
| Capital expenditures | $374000.00 | $1.37M | $739000.00 | $272000.00 | $695000.00 | $576000.00 | $723000.00 | $432000.00 | $621000.00 | $2.41M | $732000.00 | $3.75M | $43.06M | $20.68M | $14.71M | $23.28M | $20.17M | $21.16M | $267000.00 | $102000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $2.02M | $2.44M | $5.75M | $8.47M | $7.82M | $8.08M | $5.34M | $6.15M | $9.20M | $11.73M | $15.06M | $9.09M | $14.68M | $19.33M | $25.71M | $32.96M | $31.65M | $27.36M | $12.38M | $9.08M |
| Free cash flow | $-14.85M | $-17.44M | $-18.08M | $-6.41M | $-24.63M | $-26.47M | $-8.80M | $-19.91M | $-6.30M | $-36.13M | $-66.61M | $7.43M | $-5.91M | $-165.08M | $155.16M | $-256.53M | $-243.80M | $-246.00M | $-67.41M | $-97.31M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $5.98M | $4.91M | $-11.49M | $-4.16M | $63.45M | $-47.42M | $27.77M | $90.75M | $-62.17M | $51.35M | $47.81M | $-79.68M | — | — | — |